openPR Logo
Press release

South East Asia Pharmaceutical Contract Development and Manufacturing Market to be worth $4.2 Billion by 2030

02-20-2024 11:43 AM CET | Health & Medicine

Press release from: Meticulous Research®

/ PR Agency: Meticulous Research
Meticulous Research® Unveils Insights into South East Asia Pharmaceutical Contract Development and Manufacturing Market

Cutting-edge Report Forecasts Market Valuation of $4.2 Billion by 2030

[Redding, California] - Meticulous Research®, a globally renowned market research firm, has announced the release of its latest comprehensive analysis, titled 'South East Asia Pharmaceutical Contract Development and Manufacturing Market by Service,' offering invaluable insights into the dynamic landscape of the pharmaceutical contract development and manufacturing sector in the South East Asia region.

Download Complete Free Sample PDF Copy Here: https://www.meticulousresearch.com/download-sample-report/cp_id=5675

Market Projections:

According to the findings of this groundbreaking report, the South East Asia Pharmaceutical Contract Development and Manufacturing Market is poised to achieve a remarkable valuation of $4.2 billion by 2030, reflecting a robust CAGR of 8.3% from 2023 to 2030. This unprecedented growth trajectory is attributed to several key factors driving demand within the pharmaceutical contract development and manufacturing landscape.

Key Growth Drivers:

The expansion of the South East Asia pharmaceutical contract development and manufacturing market is fueled by the complex manufacturing requirements of the pharmaceutical industry, coupled with increasing investments in pharmaceutical research and development. Additionally, factors such as the rising demand for generic medicines and biologics, patent expiration, and growing government funding for drug development and research further propel market growth. Moreover, the burgeoning demand for cell and gene therapies, personalized medicines, as well as the growth in high potency active pharmaceutical ingredients (HPAPI) and antibody-drug conjugates (ADC) markets, are expected to present significant growth opportunities. However, challenges such as the shortage of skilled professionals pose obstacles to market expansion.

Check complete table of contents with list of table and figures: https://www.meticulousresearch.com/product/south-east-asia-pharmaceutical-contract-development-and-manufacturing-market-5675

Market Segmentation Insights:

The report provides a detailed segmentation analysis, encompassing various aspects such as service type, end-user analysis, and geographical perspectives. Among the service types studied, the pharmaceutical manufacturing services segment is projected to hold the largest market share in 2023, driven by the imperative need to reduce manufacturing costs and expedite the introduction of new drugs to the market.

Regional Analysis:

The report thoroughly examines major countries in the South East Asia region, including Indonesia, Vietnam, Thailand, Singapore, Philippines, Malaysia, among others. Singapore, in particular, is anticipated to exhibit the highest CAGR during the forecast period, propelled by its robust healthcare infrastructure and conducive environment for pharmaceutical research and development.

Have Any Query? Ask To Analyst: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5675

Key Players:

The South East Asia pharmaceutical contract development and manufacturing market features several prominent players, including Aenova Group, Wuxi Biologics, Vetter Pharma International, and Catalent, among others.

Asia-Pacific
Office No-202, 203,204,205,206
2nd Floor, Pushpak Business Hub,
Wakad, Pimpri-Chinchwad,
411057, India.

We are the trusted research partners for leading businesses around the world, providing market intelligence focused towards building revenue transformation strategies. Our research is used by Fortune 500 organizations to attain success by scouting next generation revenue opportunities well ahead of their competition.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release South East Asia Pharmaceutical Contract Development and Manufacturing Market to be worth $4.2 Billion by 2030 here

News-ID: 3391262 • Views:

More Releases from Meticulous Research®

Nutraceutical Products Market: Growth Trends and Future Outlook to 2030| Meticulous Research®
Nutraceutical Products Market: Growth Trends and Future Outlook to 2030| Meticul …
The nutraceutical products market is witnessing steady and significant growth, driven by a rising awareness of health, nutrition, and disease prevention. Between 2023 and 2030, the market is projected to expand at a compound annual growth rate of 7.8%, ultimately reaching a value of $691.87 billion by the end of the forecast period. This growth reflects a major shift in consumer mindset, as individuals increasingly seek products that offer both
Global Feed Additives Market Outlook: Trends, Growth Drivers, and Regional Insights to 2030 | Meticulous Research®
Global Feed Additives Market Outlook: Trends, Growth Drivers, and Regional Insig …
The way we feed our livestock is changing, and feed additives are at the heart of that transformation. Over the next decade, the global feed additives market is expected to surpass $51 billion, fueled by rising demand for meat and dairy products, concerns over animal health, and a push toward more sustainable farming practice. Farmers today are no longer just feeding animals they are strategically nourishing them to improve growth,
Global Home Medical Equipment Market: Trends, Insights, and Forecast to 2030 | Meticulous Research®
Global Home Medical Equipment Market: Trends, Insights, and Forecast to 2030 | M …
The home medical equipment market is growing steadily and is projected to reach nearly $63 billion by 2030. These devices are designed to help people manage their health at home, allowing patients to remain independent while receiving the care they need. From respiratory devices to mobility aids, these products make it possible for individuals to maintain a better quality of life without relying entirely on hospital care. They are especially
Global Membrane Filtration Technologies Market: Trends, Growth Drivers, and Regional Insights to 2030 | Meticulous Research®
Global Membrane Filtration Technologies Market: Trends, Growth Drivers, and Regi …
The membrane filtration technologies market is steadily expanding, with expectations to hit $22.2 billion by 2030. Over the past few years, industries and municipalities alike have faced increasing pressure to manage water more efficiently. Water scarcity, environmental regulations, and operational needs have created a situation where traditional water treatment methods are no longer sufficient. Businesses are turning toward membrane filtration technologies as a solution that offers both reliability and precision. Water

All 5 Releases


More Releases for Asia

Asia Private Equity Firm, Asia Private Equity Management, Asia Private Equity Se …
The private equity market in China has been rapidly growing in recent years. Private equity (PE) refers to the purchase of shares in a company that are not publicly traded on a stock exchange. PE firms typically target companies that are undervalued or in need of capital for growth, and aim to improve the company's operations and financial performance before selling it at a higher value. https://boomingfaucet.com/ Asia Private Equity Consulting E-mail:nolan@pandacuads.com In China,
South East Asia Business Jet Market And Top Key Players are Asia Corporate Jet, …
By 2022, the South East Asia Business Jet Markets estimated to reach US$ XX Mn, up from US$ XX Mn in 2016, growing at a CAGR of XX% during the forecast period. The Global Business Jet Market, currently at 21 million USD, contributes the highest share in the market and is poised to grow at the fastest rate in the future. The three broad categories of business jets are Small,
LIXIL Asia Presents Asia Pacific Property Awards
Through its power brands GROHE and American Standard, LIXIL Asia signs a three-year deal to become the Headline Sponsor of the Asia Pacific Property Awards from 2019 until 2022. 23rd January 2019: The International Property Awards, first established in 1993, are open to residential and commercial property professionals from around the globe. They celebrate the highest levels of achievement by companies operating within the architecture, interior design, real estate and property
PEOPLEWAVE WINS ASIA TECH PODCAST PITCHDECK ASIA 2019 AWARDS
15 January 2019, Singapore – Peoplewave, Asia’s leading data-driven HR technology company, won the Asia Tech Podcast (ATP) Pitchdeck Asia 2019 Awards, being awarded “Startup Most Likely to Succeed in 2019". The 2019 Pitchdeck Asia Awards is an opportunity for the Asian Startup Ecosystem to shine a spotlight on some of its best startups. The awards were decided by a public vote. More than 7,200 votes were cast by registered LinkedIn
Undersea Defence Technology Asia, UDT Asia 2011
Latest Military Diving Technologies featured in UDT Asia Equipping Asia’s navies with the latest diving technology for asymmetric warfare and operations SINGAPORE, 17 October 2011 - Naval diving and underwater special operations is a field that is seeing increased attention and investment amongst navies in Asia. Units such as the Indonesian Navy‟s KOPASKA, the Republic of Singapore Navy‟s Naval Diving Unit (NDU), the Royal Malaysian Navy‟s PASKAL are increasingly utilising specialised equipment for conducting
Asia Diligence – Specialist Investigative Due Diligence for Asia & Beyond
Asia Diligence today announced the opening of its European Customer Services office in the United Kingdom. The office is to be managed by Steve Fowler and will focus on providing services to Asia Diligence’s European customers. Asia Diligence is also planning to open a US office in the near future, which will provide customer service to its US and North American clients. Asked to comment on the move, Luke Palmer, the